Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19

PURPOSE: Evidence is emerging that a significant percentage of COVID-19 cases experience symptom persistence beyond 30 days and go on to develop post-acute sequelae. Our objective was to compare the risk for COVID-19 symptom persistence by self-reported use of medications for autoimmune disease amon...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Gen Med
Hlavní autoři: Dreyer, Nancy, Petruski-Ivleva, Natalia, Albert, Lisa, Mohamed, Damir, Brinkley, Emma, Reynolds, Matthew, Toovey, Stephen
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323859/
https://ncbi.nlm.nih.gov/pubmed/34345182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S313486
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky